Atrophy

Atrophy is the partial or complete wasting away of a part of the body. Causes of atrophy include poor nourishment, poor circulation, loss of hormonal support, loss of nerve supply to the target organ, disuse or lack of exercise or disease intrinsic to the tissue itself. Hormonal and nerve inputs that maintain an organ or body part are referred to as trophic.Atrophy is a general physiological process of reabsorption and breakdown of tissues, involving apoptosis on a cellular level. When it occurs as a result of disease or loss of trophic support due to other disease, it is termed pathological atrophy, although it can be a part of normal body development and homeostasis as well. (From the Wikpedia article Atrophy.)

Download PDF containing detailed information.

Recent Publications on Atrophy:
Executive control function, brain activation and white matter hyperintensities in older adults. Context: Older adults responding to executive control function (ECF) tasks...	20th November, 2009	Department of Bioengineering, School of Engineering, University of	Neuroimage. 2009 Nov 13. DOI Direct Link
Oxaliplatin-induced loss of phosphorylated heavy neurofilament subunit neuronal immunoreactivity in rat DRG tissue. ABSTRACT: BACKGROUND: Oxaliplatin and related chemotherapeutic drugs cause...	20th November, 2009		Mol Pain. 2009 Nov 18;5(1):66. DOI Direct Link
Genetic Study of Demyelinating form of Autosomal-Recessive Charcot-Marie-Tooth Diseases in a Turkish Family. Charcot-Marie-Tooth (CMT) disease is a clinically and genetically...	20th November, 2009	Department of Medical Biology, Suleyman Demirel University, Faculty of	Int J Neurosci. 2009;119(8):1179-1189.
SOD1 G93D mutation presenting as paucisymptomatic amyotrophic lateral sclerosis. We describe a patient with a familial form of amyotrophic lateral...	20th November, 2009	Istituto di Neurologia.	Amyotroph Lateral Scler. 2009;10(5-6):479-482.
The importance of the SMN genes in the genetics of sporadic ALS. The human genome contains two SMN (survival motor neuron) genes: SMN1, the...	20th November, 2009	ALS Centre.	Amyotroph Lateral Scler. 2009;10(5-6):436-440.
→View more research publications.

Press Releases About Atrophy:
Repligen Reports Second Quarter Fiscal Year 2010 Financial Results	5th November, 2009	Repligen Corporation	WALTHAM, Mass., Nov. 5 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) today reported results for the second quarter of fiscal year 2010, ended September 30, 2009. Total revenue for the
Families of Spinal Muscular Atrophy Licenses Potential Treatment for SMA to Repligen Corporation	22nd October, 2009	Families of Spinal Muscular Atrophy	ELK GROVE VILLAGE, Ill., Oct. 22 /PRNewswire-USNewswire/ -- Families of Spinal Muscular Atrophy (FSMA) announced today that it has entered into a groundbreaking exclusive license agreement with
Repligen Licenses Potential Treatment for Spinal Muscular Atrophy	22nd October, 2009	Repligen Corporation	WALTHAM, Mass., Oct. 22 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) announced today that it has entered into an exclusive license agreement with Families of Spinal Muscular Atrophy
Reportlinker Adds Therapeutics for Memory and Cognition Disorders Report	3rd September, 2009	Reportlinker	-- Analyzes the market outlook, trends, and challenges. Chapter-1: SUMMARY SUMMARY TABLE WORLDWIDE POTENTIAL MARKET FOR MEMORY/COGNITION THERAPEUTICS, BY DISEASE AREA, THROUGH 2014 ($
Families of Spinal Muscular Atrophy Announces Latest Developments on Three SMA Drug Discovery Programs	19th June, 2009	Families of Spinal Muscular Atrophy	LIBERTYVILLE, Ill., June 18 /PRNewswire-USNewswire/ -- Families of Spinal Muscular Atrophy has just released details of the latest developments for the Families of SMA funded therapeutic pipeline.

BioNews Results for Atrophy:
White Matter Lesions and Lacunar Infarcts Are Independently and Differently Associated with Brain Atrophy: The SMART-MR Study	MDLinx:  Nov 18 2009 12:28PM Matching: atrophy
Cancer: Findings from University of Liverpool advance knowledge in cancer	NewsRX:  Nov 15 2009 6:05AM Matching: atrophy
Unique Therapeutic Candidate To Treat Spinal Muscular Atrophy Identified	MedIndia:  Nov 9 2009 1:27PM Matching: atrophy
Medical News: Drug Candidate For Treating Spinal Muscular Atrophy Identified By Researchers	BioFind:  Nov 5 2009 3:57PM Matching: atrophy
Drug Candidate For Treating Spinal Muscular Atrophy Identified By Researchers	Medical News Today:  Nov 5 2009 12:44PM Matching: atrophy
Promote your company here: BioNewsCast - Press Release Distribution	→View more news.

Atrophy Patents:
US Patent No.	Title
7611847	Method for identifying an intestinal phenotype
7613343	Nosologic system of diagnosis
7613495	MRI detection and staging of Parkinson's disease and detection of progressive supranuclear palsy
7613515	High frequency vagal blockage therapy
7613516	Pelvic disorder treatment device
→View more patents.

Companies working in the area of Atrophy from Bioportfolio's Biocorporate database :
Company Name
Neurotech USA, Inc Neurotech is a biotechnology company dedicated to the development of sight-saving therapeutics for chronic retinal diseases. Retinal diseases represent significant unmet medical needs for which new... www.neurotechusa.com/        View full profile
QuatRx Pharmaceuticals QuatRx Pharmaceuticals Company is a pharmaceutical company focused on discovering, licensing, developing and commercializing compounds in the endocrine, metabolic and cardiovascular therapeutic areas.... www.quatrx.com/        View full profile

BioPortfolio Ltd. offers e-mail and postal lists for Atrophy scientists - we have details of around 6283 individuals working on Atrophy .